PRF Technologies Ltd. (PRFX) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Tel Aviv, Israel. 현재 CEO는 Ehud Geller.
PRFX 을(를) 보유 IPO 날짜 2020-09-01, 2 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $216.63K.
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
